Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Microchimerism in salivary glands after blood- and marrow-derived stem cell transplantation.

Tran SD, Redman RS, Barrett AJ, Pavletic SZ, Key S, Liu Y, Carpenter A, Nguyen HM, Sumita Y, Baum BJ, Pillemer SR, Mezey E.

Biol Blood Marrow Transplant. 2011 Mar;17(3):429-33. doi: 10.1016/j.bbmt.2010.09.021. Epub 2010 Dec 4.

2.

Anti-CD3 monoclonal antibody treatment in newly diagnosed Type 1 diabetes patients: a hypothetical modelling analysis.

Smith-Palmer J, Curtis BH, Boye KS, Goodall G, Pillemer SR.

Diabet Med. 2010 Feb;27(2):189-96. doi: 10.1111/j.1464-5491.2009.02902.x.

PMID:
20546263
3.

Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus.

Beigel JH, Nordstrom JL, Pillemer SR, Roncal C, Goldwater DR, Li H, Holland PC, Johnson S, Stein K, Koenig S.

Antimicrob Agents Chemother. 2010 Jun;54(6):2431-6. doi: 10.1128/AAC.01178-09. Epub 2010 Mar 29.

4.

Phase-1 study of siplizumab in the treatment of pediatric patients with at least grade II newly diagnosed acute graft-versus-host disease.

Brochstein JA, Grupp S, Yang H, Pillemer SR, Geba GP.

Pediatr Transplant. 2010 Mar;14(2):233-41. doi: 10.1111/j.1399-3046.2009.01223.x. Epub 2009 Aug 11.

PMID:
19671093
5.

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.

Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH; National Arthritis Data Workgroup.

Arthritis Rheum. 2008 Jan;58(1):15-25. doi: 10.1002/art.23177.

6.

Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept.

Mavragani CP, Niewold TB, Moutsopoulos NM, Pillemer SR, Wahl SM, Crow MK.

Arthritis Rheum. 2007 Dec;56(12):3995-4004.

7.

Lymphoma and other malignancies in primary Sjögren's syndrome.

Pillemer SR.

Ann Rheum Dis. 2006 Jun;65(6):704-6. No abstract available.

8.

Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma.

Gelber AC, Pillemer SR, Baum BJ, Wigley FM, Hummers LK, Morris S, Rosen A, Casciola-Rosen L.

Ann Rheum Dis. 2006 Aug;65(8):1028-32. Epub 2006 Jan 13.

9.

Serum lipid levels in Sjögren's syndrome.

Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR.

Rheumatology (Oxford). 2006 Apr;45(4):481-4. Epub 2005 Nov 22.

PMID:
16303821
10.

Adult heart block is associated with disease activity in primary Sjögren's syndrome.

Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR.

Scand J Rheumatol. 2005 Sep-Oct;34(5):383-6.

PMID:
16234186
11.
12.

Outcome measures for Sjögren's syndrome, April 10-11, 2003, Bethesda, Maryland, USA.

Pillemer SR, Smith J, Fox PC, Bowman SJ.

J Rheumatol. 2005 Jan;32(1):143-9. Review. No abstract available.

PMID:
15630740
13.

Central nervous system disease in primary Sjogrens syndrome: the role of magnetic resonance imaging.

Morgen K, McFarland HF, Pillemer SR.

Semin Arthritis Rheum. 2004 Dec;34(3):623-30. Review.

PMID:
15609267
14.

Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome.

Pillemer SR, Brennan MT, Sankar V, Leakan RA, Smith JA, Grisius M, Ligier S, Radfar L, Kok MR, Kingman A, Fox PC.

Arthritis Rheum. 2004 Aug 15;51(4):601-4.

15.

Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.

Sankar V, Brennan MT, Kok MR, Leakan RA, Smith JA, Manny J, Baum BJ, Pillemer SR.

Arthritis Rheum. 2004 Jul;50(7):2240-5.

16.

Prominent adverse effects of thalidomide in primary Sjögren's syndrome.

Pillemer SR, Leakan RA, Sankar V, Manny J, Baum BJ, Smith J, Chaudhry U, Fox PC, Radfar L, Ligier S, Brennan MT.

Arthritis Rheum. 2004 Jun 15;51(3):505-6. No abstract available.

17.

Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.

Pillemer SR, Casciola-Rosen L, Baum BJ, Rosen A, Gelber AC.

J Rheumatol. 2004 Jun;31(6):1121-5.

PMID:
15170924
18.

The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model.

Vitolo JM, Cotrim AP, Sowers AL, Russo A, Wellner RB, Pillemer SR, Mitchell JB, Baum BJ.

Clin Cancer Res. 2004 Mar 1;10(5):1807-12.

19.

Clinical trials, outcome measures, and response criteria.

Pillemer SR, Tilley B.

J Rheumatol. 2004 Mar;31(3):407-10. No abstract available.

PMID:
14994378
20.

Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren's syndrome.

Kok MR, Yamano S, Lodde BM, Wang J, Couwenhoven RI, Yakar S, Voutetakis A, Leroith D, Schmidt M, Afione S, Pillemer SR, Tsutsui MT, Tak PP, Chiorini JA, Baum BJ.

Hum Gene Ther. 2003 Nov 20;14(17):1605-18.

PMID:
14633403
21.

Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome.

Kok MR, Baum BJ, Tak PP, Pillemer SR.

Ann Rheum Dis. 2003 Nov;62(11):1038-46. Review.

22.

Fungal load and candidiasis in Sjögren's syndrome.

Radfar L, Shea Y, Fischer SH, Sankar V, Leakan RA, Baum BJ, Pillemer SR.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Sep;96(3):283-7.

PMID:
12973284
23.

Sex steroid hormones in primary Sjögren's syndrome.

Brennan MT, Sankar V, Leakan RA, Grisius MM, Collins MT, Fox PC, Baum BJ, Pillemer SR.

J Rheumatol. 2003 Jun;30(6):1267-71.

PMID:
12784401
24.

Differentiation of human bone marrow-derived cells into buccal epithelial cells in vivo: a molecular analytical study.

Tran SD, Pillemer SR, Dutra A, Barrett AJ, Brownstein MJ, Key S, Pak E, Leakan RA, Kingman A, Yamada KM, Baum BJ, Mezey E.

Lancet. 2003 Mar 29;361(9363):1084-8.

PMID:
12672312
25.

Salivary gland delivery of pDNA-cationic lipoplexes elicits systemic immune responses.

Sankar V, Baccaglini L, Sawdey M, Wheeler CJ, Pillemer SR, Baum BJ, Atkinson JC.

Oral Dis. 2002 Nov;8(6):275-81.

PMID:
12477057
26.

Clinical evaluation of patients with temporomandibular joint implants.

Ta LE, Phero JC, Pillemer SR, Hale-Donze H, McCartney-Francis N, Kingman A, Max MB, Gordon SM, Wahl SM, Dionne RA.

J Oral Maxillofac Surg. 2002 Dec;60(12):1389-99.

PMID:
12464999
27.

Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers.

Radfar L, Kleiner DE, Fox PC, Pillemer SR.

Arthritis Rheum. 2002 Oct 15;47(5):520-4.

28.

Elevated blood pressure is not related to saliva flow in patients with Sjögren's syndrome.

Sankar V, Brennan MT, Radfar L, Leakan RA, Pillemer SR.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Aug;94(2):179-83.

PMID:
12221385
29.

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH; European Study Group on Classification Criteria for Sjögren's Syndrome.

Ann Rheum Dis. 2002 Jun;61(6):554-8. Review.

30.

Risk factors for positive minor salivary gland biopsy findings in Sjögren's syndrome and dry mouth patients.

Brennan MT, Sankar V, Leakan RA, Kleiner D, Atkinson JC, Wilkinson WE, Baum BJ, Pillemer SR.

Arthritis Rheum. 2002 Apr 15;47(2):189-95.

31.

Xerostomia and the geriatric patient.

Ship JA, Pillemer SR, Baum BJ.

J Am Geriatr Soc. 2002 Mar;50(3):535-43. Review.

PMID:
11943053
32.

Widespread pain and Sjögren's syndrome.

Pendarvis WT, Pillemer SR.

J Rheumatol. 2001 Dec;28(12):2657-9.

PMID:
11764213
33.

Oral manifestations in patients with aplastic anemia.

Brennan MT, Sankar V, Baccaglini L, Pillemer SR, Kingman A, Nunez O, Young NS, Atkinson JC.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Nov;92(5):503-8.

PMID:
11709685
34.

Protection from experimental endotoxemia by a recombinant adeno-associated virus encoding interleukin 10.

Yamano S, Scott DE, Huang LY, Mikolajczyk M, Pillemer SR, Chiorini JA, Golding B, Baum BJ.

J Gene Med. 2001 Sep-Oct;3(5):450-7.

PMID:
11601758
35.

Focal sialadenitis in patients with early synovitis.

Brennan MT, Pillemer SR, Goldbach-Mansky R, El-Gabalawy H, Schumacher HR Jr, Fox PC.

Clin Exp Rheumatol. 2001 Jul-Aug;19(4):444-6.

PMID:
11491501
36.

Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota.

Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ 3rd, O'Fallon WM, Fox PC.

Mayo Clin Proc. 2001 Jun;76(6):593-9.

PMID:
11393497
37.

Genealogy construction in a historically isolated population: application to genetic studies of rheumatoid arthritis in the Pima Indian.

Lin JP, Hirsch R, Jacobsson LT, Scott WW, Ma LD, Pillemer SR, Knowler WC, Kastner DL, Bale SJ.

Genet Med. 1999 Jul-Aug;1(5):187-93.

PMID:
11256671
38.

Sjögren's syndrome: a possible pathogenetic mechanism involving somatostatin.

Baccaglini L, Pillemer SR, Baum BJ.

Oral Dis. 2000 Sep;6(5):264-6.

PMID:
11002406
39.

Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.

Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR.

Arthritis Rheum. 2000 Apr;43(4):872-80.

40.

Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group.

Tilley BC, Pillemer SR, Heyse SP, Li S, Clegg DO, Alarcón GS.

Arthritis Rheum. 1999 Sep;42(9):1879-88.

41.

Experiments, evidence, and explanations.

Pillemer SR.

J Altern Complement Med. 1999 Aug;5(4):323-5. No abstract available.

PMID:
10471011
42.

Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976-1992.

Martens PB, Pillemer SR, Jacobsson LT, O'Fallon WM, Matteson EL.

J Rheumatol. 1999 Jun;26(6):1296-300.

PMID:
10381046
43.

Self-administered joint counts and standard joint counts in the assessment of rheumatoid arthritis. MIRA Trial Group. Minocycline in RA.

Alarcón GS, Tilley BC, Li S, Fowler SE, Pillemer SR.

J Rheumatol. 1999 May;26(5):1065-7.

PMID:
10332969
44.

Rheumatoid arthritis in the Pima Indians: the intersection of epidemiologic, demographic, and genealogic data.

Hirsch R, Lin JP, Scott WW Jr, Ma LD, Pillemer SR, Kastner DL, Jacobsson LT, Bloch DA, Knowler WC, Bennett PH, Bale SJ.

Arthritis Rheum. 1998 Aug;41(8):1464-9.

PMID:
9704646
45.

Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, Heyse SP, Hirsch R, Hochberg MC, Hunder GG, Liang MH, Pillemer SR, Steen VD, Wolfe F.

Arthritis Rheum. 1998 May;41(5):778-99.

PMID:
9588729
46.

Hip osteoarthritis prevalence estimates by three radiographic scoring systems.

Hirsch R, Fernandes RJ, Pillemer SR, Hochberg MC, Lane NE, Altman RD, Bloch DA, Knowler WC, Bennett PH.

Arthritis Rheum. 1998 Feb;41(2):361-8.

PMID:
9485095
47.

Enlarged acetabular labra in the Pima Indians.

Hirsch R, Fernandes RJ, Pillemer SR, Hochberg MC, Lane NE, Altman RD, Knowler WC, Bennett PH.

J Rheumatol. 1997 Nov;24(11):2210-2.

PMID:
9375885
48.

The neuroscience and endocrinology of fibromyalgia.

Pillemer SR, Bradley LA, Crofford LJ, Moldofsky H, Chrousos GP.

Arthritis Rheum. 1997 Nov;40(11):1928-39. No abstract available.

PMID:
9365080
49.

A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group.

Tuttleman M, Pillemer SR, Tilley BC, Fowler SE, Buckley LM, Alarcón GS, Trentham DE, Neuner R, Clegg DO, Leisen JC, Heyse SP.

J Rheumatol. 1997 Oct;24(10):1910-5.

PMID:
9330931
50.

Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial.

Bluhm GB, Sharp JT, Tilley BC, Alarcon GS, Cooper SM, Pillemer SR, Clegg DO, Heyse SP, Trentham DE, Neuner R, Kaplan DA, Leisen JC, Buckley L, Duncan H, Tuttleman M, Li S, Fowler SE.

J Rheumatol. 1997 Jul;24(7):1295-302.

PMID:
9228128

Supplemental Content

Loading ...
Support Center